Happy to share our new study on the mechanical regulation of ovarian cancer invasion into adipose tissues! Here we develop adipose tissue-mimicking organo-hydrogels to investigate how cells invade these tissues, a central process in the establishment of metastases!
Over 35 million new cases are predicted in 2050, a 77% increase vs cases in 2022. Tobacco🚬, alcohol🍺🍷 & obesity🍔 are key lifestyle risk factors behind the increasing incidence.
Air pollution remains a major environmental risk factor🌬️.
https://t.co/jQyiCQdZH1
@NathalieJuYa@NTNU Important discussion around how to maintain national uniqueness in countries like those in the Northern Europe, while simultaneously supporting international cooperation and global developments 💡
The Norwegian government wants to implement a new rule requiring all temporary employees (PhD students and postdocs) to obtain 15 credits in Norwegian language within their 3 years contract. This piece written by Karina Rose Mahan @NTNU is very relevant! https://t.co/yWdqEgL1cd
Dr. @asmundflobak's team at @NTNUnorway presents a systematic 📖 #review of studies that tested the performance of patient-derived #organoids to predict the effect of anti-cancer therapies in #ColorectalCancer, for chemotherapies, and more!
@SciReports | https://t.co/Ql6UyMyEcv
”The drug efficacy testing in 3D cultures platform identifies effective drugs for ovarian cancer patients”
Congratulations and thank you for the opportunity to participate Brinton Seashore-Ludlow, Emma Åkerlund and all co-authors!
https://t.co/VciQDovKwx
We recruit one PHD candidate for cell lab work on functional precision medicine. Colon cancer cells direclty from patients are exposed to drugs to find the best therapy for each patient. Deadline Nov 22nd: https://t.co/9ct2tZGagV
@NTNU@SINTEF @StOlavshospital @fkbmatrix
Fantastic news! Congratulations to NTNU professors James R. Dawson and Thorsten Hamann. The two ERC SYNERGY grants represent two important research topics, which will be exciting to follow in future.
Today Cell, Cancer Cell and Cell Reports Medicine are pleased to publish the 1st wave of Pan-#Cancer multiomics papers looking at over 1000 patients across 10 #tumor types from @theNCI Clinical Proteomic Tumor Analysis Consortium #CPTAC (1/n) @Cancer_Cell@CellRepMed#openaccess
This work resulted from Lara Closset’s efforts during the pandemic that continued until now and great contributions from @okangultekinphd@LehtiLab @DhifafSarhan @Dr_S_Salehi
Excited to announce our next session: "BMP signaling and vascular biology" chaired by Paul Yu Aug. 23. Mohamed Al-Shabrawey and Lei Wang are presenting their interesting work. Please share! Register here: https://t.co/bUAaN3qHbP
Our new review is out (my first last author)! Here we discuss how cancer therapies reshape the #ECM - #immune microenvironment crosstalk and how can we exploit it to improve therapy response. https://t.co/xRe3hO4eqZ
Huge congratulations Viviam and Marco✨🏅
Wonderful to do research with the young talents. Looking forward to hear more what you learned and experienced in this exciting meeting!
@asmundflobak @mtrkuiper @eirini_tsi